mRNA vaccine booster dose antibodies – quantity not quality

Coronavirus, Moderna, Pfizer/Biontech, Revaccination, Vaccine, Vaccine Breakthrough, Vaccine Waning, Variants

“These results suggest that boosting vaccinated individuals with currently available mRNA vaccines would produce a quantitative increase in plasma neutralizing activity but not the qualitative advantage against variants obtained by vaccinating convalescent individuals.”

Biorxiv preprint: Antibody Evolution after SARS-CoV-2 mRNA Vaccination


Image by Johaehn from Pixabay

** This post was originally published on August 10, 2021 **